4//SEC Filing
MacLeod Roderick H. 4
Accession 0001444380-25-000030
CIK 0001444380other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:28 PM ET
Size
9.3 KB
Accession
0001444380-25-000030
Insider Transaction Report
Form 4
NEVRO CORPNVRO
MacLeod Roderick H.
SVP, Chief Financial Officer
Transactions
- Award
Common Stock
2025-02-28+742→ 132,101 total - Tax Payment
Common Stock
2025-02-28$5.72/sh−805$4,605→ 130,904 total - Tax Payment
Common Stock
2025-03-02$5.72/sh−1,143$6,538→ 129,761 total - Tax Payment
Common Stock
2025-02-28$5.72/sh−392$2,242→ 131,709 total
Footnotes (2)
- [F1]Represents Performance Stock Units ("PSUs") initially granted on February 28, 2022 that were subject to a performance-based vesting condition. The Compensation Committee of the Issuer certified the achievement of the second milestone vesting condition upon which a portion of the PSUs vested.
- [F2]Includes 100,694 restricted stock units.
Documents
Issuer
NEVRO CORP
CIK 0001444380
Entity typeother
Related Parties
1- filerCIK 0001815111
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:28 PM ET
- Size
- 9.3 KB